Oxaliplatin Injection, Solution
Product Images NDC 25021-233

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 25021-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxa0c 0006 01

Chemical structure diagram of oxaliplatin, depicting its platinum center bonded to a cyclohexane ring with two amine groups and two oxalate ligands, illustrating the drug's molecular configuration.*

FDA Label Image

Oxa0c 0006 02

A Kaplan-Meier survival curve showing disease-free survival (DFS) probability over time in months, comparing two treatment arms labeled FOLFOX4 and LV5FU2. The graph includes a legend, number of events, hazard ratio with 95% confidence interval, stratified logrank test p-value, and a table of patients at risk over time for each arm.*

FDA Label Image

Oxa0c 0006 03

A Kaplan-Meier survival curve chart depicting Disease-Free Survival (DFS) probability over time in months. The chart compares two treatment arms labeled FOLFOX4 - DUKES C and LV5FU2 - DUKES C, showing their DFS probabilities through 72 months. Additional statistical data including Hazard Ratio with 95% confidence interval and Logrank Test p-value are noted.*

FDA Label Image

Oxa0c 0006 04

A Kaplan-Meier survival curve chart comparing median survival of patients receiving oxaliplatin injection plus FU/LV, oxaliplatin injection plus irinotecan, and irinotecan plus FU/LV over 24 months. The y-axis shows the percentage of patients surviving, and the x-axis shows time in months, with statistical significance noted (p<0.0001).*

FDA Label Image

Oxa0c 0006 05

Label for oxaliplatin Injection, USP 50 mg per 10 mL (5 mg per mL) intravenous solution by Sagent Pharmaceuticals. The label states it is a single-dose vial, preservative-free, and a cytotoxic agent with instructions to avoid mixing with sodium chloride solutions. Storage conditions and manufacturer details are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.